secwatch.observer — SEC 8-K summary
======================================

Issuer:     CME GROUP INC. (CME)
CIK:        0001156375
Form:       8-K
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0001193125-25-079725
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CME Group and S&P Global sell OSTTRA joint venture to KKR for $3.1B
-------------------------------------------------------------------

- Total enterprise value of $3.1 billion; proceeds split 50/50 between CME and S&P Global.
- Transaction expected to close in second half of 2025, subject to regulatory approvals.
- OSTTRA co-CEOs Guy Rowcliffe and John Stewart to remain in their current roles.
- KKR to support OSTTRA with increased technology investments and an employee equity program.
- OSTTRA, established in 2021, provides post-trade solutions for OTC markets including interest rates, FX, credit, and equities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156375/000119312525079725/0001193125-25-079725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156375/000119312525079725/d857621d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-079725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer